** Shares of pot firm Trulieve Cannabis TRUL.CD rise ~2.8%
to C$15.30
** Co's Q1 loss narrows to $23.1 million, from $64.1 million
a year earlier, driven by higher sales and robust demand
** Reports Q1 revenue of $297.6 million compared to
estimates of $285.9 million - LSEG data
** "Trulieve has significant capital allocation optionality,
positioning the company well for potential Florida adult-use
legalization, or expansion in other markets," - ATB Capital
Markets
** Including session's moves, stock is up ~123% YTD
(Reporting by Vallari Srivastava in Bengaluru)
((Srivastava.Vallari@thomsonreuters.com;))